BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sasineprocel readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Sasineprocel\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06344026-1576@assetmemo.bio
DTSTAMP:20261121T005406Z
DTSTART;VALUE=DATE:20270330
DTEND;VALUE=DATE:20270331
SUMMARY:Sasineprocel: Phase 1 readout est. (NCT06344026)
DESCRIPTION:Sasineprocel\, phase 1\, Parkinson's Disease.\nStudy: Phase 1/2
 a Study of ANPD001 in Parkinson Disease\nEstimated primary completion: 30 
 March 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/sasinepro
 cel#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 06344026
URL:https://assetmemo.bio/drug/sasineprocel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
